IgA nephropathy: Immune mechanisms beyond IgA mesangial deposition

Slides:



Advertisements
Similar presentations
Volume 72, Issue 6, Pages (September 2007)
Advertisements

Volume 82, Issue 2, Pages (July 2012)
Volume 70, Issue 3, Pages (August 2006)
The CD19–CD21 Complex Regulates Signal Transduction Thresholds Governing Humoral Immunity and Autoimmunity  Thomas F Tedder, Makoto Inaoki, Shinichi Sato 
The Leptin Connection: Regulatory T Cells and Autoimmunity
Volume 81, Issue 2, Pages (January 2012)
Kidney Macrophages: Unique Position Solves a Complex Problem
Germaine Wong, Jeremy R. Chapman, Jonathan C. Craig 
The Th17 immune response in renal inflammation
Gluten and IgA nephropathy: you are what you eat?
Nat. Rev. Nephrol. doi: /nrneph
Innate immunity as a driving force in renal disease
Link between intracellular pathogens and cardiovascular diseases
The changing face of schistosomal glomerulopathy
Figure 2 Influence of fucosylation on IgG effector functions
Volume 73, Issue 5, Pages (March 2008)
Neil J. Weiner, Jeffrey W. Goodman, Paul L. Kimmel 
Interleukin-17 Kick-Starts T Helper 1 Cell Differentiation
Volume 71, Issue 8, Pages (April 2007)
Volume 84, Issue 2, Pages (August 2013)
The pathophysiology of anaphylaxis
Volume 70, Issue 7, Pages (October 2006)
Volume 70, Issue 11, Pages (December 2006)
Volume 73, Issue 4, Pages (February 2008)
The CD19–CD21 Complex Regulates Signal Transduction Thresholds Governing Humoral Immunity and Autoimmunity  Thomas F Tedder, Makoto Inaoki, Shinichi Sato 
Volume 73, Issue 7, Pages (April 2008)
Volume 95, Issue 3, Pages (March 2019)
The role of protein kinase C activation in diabetic nephropathy
Valder R Arruda, Patricia Favaro, Jonathan D Finn  Molecular Therapy 
Volume 72, Issue 3, Pages (August 2007)
William G. Couser, Richard J. Johnson  Kidney International 
Timothy A. Sutton, Pierre C. Dagher  Kidney International 
Volume 70, Issue 2, Pages (July 2006)
Stephen R. Holdsworth, A. Richard Kitching, Peter G. Tipping 
Osteopontin in diabetic nephropathy: signpost or road?
Nitric oxide and vascular remodeling: Spotlight on the kidney
Volume 66, Issue 4, Pages (October 2004)
The third World Kidney Day: Looking back and thinking forward
Volume 72, Issue 2, Pages (July 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Role of the T-cell receptor in kidney ischemia–reperfusion injury
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
Joshua D. Ooi, A. Richard Kitching  Kidney International 
Simplified diagrammatic representation of a selection of mechanisms of glomerular injury. Simplified diagrammatic representation of a selection of mechanisms.
Volume 69, Issue 8, Pages (April 2006)
Volume 71, Issue 4, Pages (February 2007)
Florian E. Togel, Christof Westenfelder 
Volume 80, Issue 3, Pages (August 2011)
Volume 82, Issue 9, Pages (November 2012)
Basophils and mast cells in renal injury
Volume 70, Issue 5, Pages (September 2006)
Organ transplantation goes to the movies
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 69, Issue 5, Pages (March 2006)
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Amylin deposition in the kidney of patients with diabetic nephropathy
Sundararaman Swaminathan, Matthew D. Griffin  Kidney International 
Volume 70, Issue 5, Pages (September 2006)
Volume 75, Issue 7, Pages (April 2009)
T cells and T-cell receptors in acute renal failure
The International Pediatric Peritonitis Registry: Starting to walk
The rise and fall of horror autotoxicus and forbidden clones
B cells and tertiary lymphoid organs in renal inflammation
Novel aspects of complement in kidney injury
Volume 80, Issue 9, Pages (November 2011)
IgA nephropathy: markers of progression and clues to pathogenesis
Novel therapies target the principal components of the immune system that contribute to LN pathogenesis. Novel therapies target the principal components.
Renoprotection with vitamin D: Specific for diabetic nephropathy?
Presentation transcript:

IgA nephropathy: Immune mechanisms beyond IgA mesangial deposition A. Rifai  Kidney International  Volume 72, Issue 3, Pages 239-241 (August 2007) DOI: 10.1038/sj.ki.5002356 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Postulated immunopathogenic mechanisms associated with IgA nephropathy in the ddY model. The simplified scheme illustrates how the pathogenic potential of an IgA immune complex (IgA-IC) glomerular immune deposit is influenced by the colocalized subclass IgA interaction with Fcγ receptors (FcγRs) on infiltrating macrophages that affects the magnitude of their activation and consequently the extent of glomerular injury. In this model, stem cells in the bone serve as a reservoir of autoimmune B cells that home to the mucosa of the gut-associated lymphoreticular tissue (GALT) to generate polymeric IgA. T-helper 1 (Th1) polarization in the GALT will lead to B-cell immunoglobulin class switching favoring IgG2a that reacts with the antigenic component of the IgA-IC, generating a detrimental complex composite of IgA-IC-IgG2a. Conversely, a Th2 bias leads to production of IgG1 reactive with IgA-IC that generates complex composite of IgA-IC-IgG1 with low nephritogenic potential. Circulating interferon-γ (IFN-γ) and interleukin-4 (IL-4) produced, respectively, by Th1 and Th2 in the GALT modulate glomerular injury by affecting FcγR expression on macrophage infiltrates and consequently the magnitude of their activation by the IgA-IC–IgG deposit. ITAM, immunoreceptor tyrosine-based activation motif; ITIM, immunoreceptor tyrosine-based inhibition motif. Kidney International 2007 72, 239-241DOI: (10.1038/sj.ki.5002356) Copyright © 2007 International Society of Nephrology Terms and Conditions